Trial Profile
An unblinded randomised study to evaluate viral resistance (viral shredding) following standard and extended duration Oseltamivir treatment in patients with influenza A/H1N1 2009
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Therapeutic Use
- Sponsors Roche
- 08 Jun 2016 Status changed from recruiting to completed.
- 27 Jul 2011 New trial record